Eramet SA (0MGV)

London


	Symbol		Exchange		Currency
	ERMT		Paris		EUR	Real-time
	ERAp		BATS Europe		EUR	Delayed
	ERMAY		OTC Markets		USD	Delayed
	0MGV		London		EUR	Real-time
	ERMT		Frankfurt		EUR	Delayed
	ERMT		Xetra		EUR	Delayed
	ERAM		Vienna		EUR	Real-time

Currency in EUR

54.58

+5.32(+10.80%)

Closed09/12

Fair Value

Day's Range

51.50

55.10

52 wk Range

45.00

113.90

0MGV Income Statement

Featured here, the Income Statement (earnings report) for Eramet SA, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

3,707

2,814

3,710

5,102

3,340

Total Revenues Growth

-1.12%

-24.09%

+31.84%

+37.52%

-34.54%

Cost Of Revenues

1,296

867

962

1,495

1,101

Gross Profit

2,411

1,947

2,748

3,607

2,239

Gross Profit Growth

+134.53%

-19.25%

+41.14%

+31.26%

-37.93%

Gross Profit Margin %

65.04%

69.19%

74.07%

70.7%

67.04%

Other Operating Expenses, Total

2,132

1,717

1,994

2,369

2,224

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+292.63%	-19.47%	+16.13%	+18.81%	-6.12%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,754	1,420	1,685	2,017	1,863
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	94	47	50	81	121

Operating Income

279

230

754

1,238

15

Operating Income Growth

-42.47%

-17.56%

+227.83%

+64.19%

-98.79%

EBIT Margin %

7.53%

8.17%

20.32%

24.26%

0.45%

Net Interest Expenses

-111

-121

-105

-97

-102

Net Interest Expenses Growth

-37.04%

-9.01%

+13.22%

+7.62%

-5.15%

Interest Expense, Total

-124

-131

-114

-106

-144

Interest And Investment Income

13

10

9

9

42

Other Non Operating Expenses, Total

-10

52

132

299

578

EBT, Excl. Unusual Items

158

161

781

1,440

491

Gain (Loss) On Sale Of Assets

-

-4

-1

-

-

Other Unusual Items, Total

-60

-213

116

-237

-390

EBT, Incl. Unusual Items

82

-49

889

1,194

100

EBT, Incl. Unusual Items Growth

-77.41%

-159.76%

+1,914.29%

+34.31%

-91.62%

EBT, Incl. Unusual Items Margin

2.21%

-1.74%

23.96%

23.4%

2.99%

Income Tax Expense

227

111

98

264

88

Net Income to Company

-145

-676

365

774

18

Minority Interest

-39

1

-67

-34

91

Net Income

-184

-675

298

740

109

Net Income Growth

-447.17%

-266.85%

+144.15%

+148.32%

-85.27%

Net Income Margin %

-4.96%

-23.99%

8.03%

14.5%

3.26%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

-184

-159

724

896

103

Basic EPS - Continuing Operations

-6.94

-6

25.34

31.25

3.6

Basic EPS - Continuing Operations Growth

-447.33%

+13.51%

+522.43%

+23.31%

-88.47%

Diluted EPS - Continuing Operations

-6.94

-6

25.24

30.84

3.54

Diluted EPS - Continuing Operations Growth

-479%

+13.51%

+520.77%

+22.19%

-88.52%

Basic Weighted Average Shares Outstanding

26.53

26.51

28.57

28.67

28.59

Diluted Weighted Average Shares Outstanding

26.53

26.51

28.69

29.04

28.94

Dividend Per Share

-

-

2.5

3.5

1.5

Dividend Per Share Growth

-

-

-

+40%

-57.14%

EBITDA

559

501

1,023

1,766

374

EBITDA Growth

-26.54%

-10.38%

+104.19%

+72.63%

-78.82%

EBITDA Margin %

15.08%

17.8%

27.57%

34.61%

11.2%

EBIT